Axis Genetics and Biomira collaborate on the development of a cancer vaccine Nov. 16, 1998 No Comments
AltaRex seeks permission to study immunological activity of OvaRex in phase II trial Nov. 11, 1998 No Comments
AltaRex moves to conduct clinical trial with OvaRex in more advanced ovarian cancer Nov. 6, 1998 No Comments
Ribi ImmunoChem withdraws European Melacine application; focuses on U.S. and Canada Nov. 3, 1998 No Comments
Positive initial clinical findings reported for first-generation GVAX vaccine for melanoma Oct. 29, 1998 No Comments
RSS